ClassID:

96377

C07H13/12 - CPC Classification

Classification description:

Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by acids having the group -X-C(=X)-X-, or halides thereof, in which each X means nitrogen, oxygen, sulfur, selenium or tellurium, e.g. carbonic acid, carbamic acid

Recent Application in this class:
#1
20250282808
2025-09-11

BILE ACID RECYCLING INHIBITORS FOR TREATMENT OF HYPERCHOLEMIA AND CHOLESTATIC LIVER DISEASE

#2
20240327446
2024-10-03

DEUTERATED NUCLEOSIDE COMPOUNDS AND USE THEREOF

#3
20240294564
2024-09-05

CD206 targeted drug delivery vehicles carrying novel bisphosphonate drug payloads via a degradable linker

#4
20240101584
2024-03-28

TARGETED DELIVERY OF 1,2,4,5 TETRAOXANE COMPOUNDS AND THEIR USES

#5
20230374055
2023-11-23

CD206 targeted drug delivery vehicles carrying novel bisphosphonate drug payloads via a degradable linker

#6
20230212211
2023-07-06

Bile acid recycling inhibitors for treatment of hypercholemia and cholestatic liver disease

#7
20230181567
2023-06-15

Liposomes Useful for Drug Delivery

#8
20230151024
2023-05-18

STING AGONISTIC COMPOUND

#9
20220144866
2022-05-12

Crystalline form of Remdesivir

#10
20210205271
2021-07-08

Mebendazole prodrugs with enhanced solubility and oral bioavailability

#11
20210137914
2021-05-13

Liposomes Useful for Drug Delivery

#12
20210107931
2021-04-15

Potent sialyltransferase inhibitors

#13
20210033617
2021-02-04

Cell labeling agent and cell labeling kit

#14
20210032250
2021-02-04

GLUCURONIDE PRODRUGS OF JANUS KINASE INHIBITORS

#15
20200207797
2020-07-02

BILE ACID RECYCLING INHIBITORS FOR TREATMENT OF HYPERCHOLEMIA AND CHOLESTATIC LIVER DISEASE

#16
20200048491
2020-02-13

Pattern forming method, under coating agent, and laminate

#17
20190284201
2019-09-19

Bis-diox(ol)ane compounds

#18
20190240329
2019-08-08

5-ALA derivatives and use thereof

#19
20190169217
2019-06-06

BILE ACID RECYCLING INHIBITORS FOR TREATMENT OF HYPERCHOLEMIA AND CHOLESTATIC LIVER DISEASE

#20
20180339990
2018-11-29

Glucuronide prodrugs of Janus kinase inhibitors

#21
20180282293
2018-10-04

Neuraminidase Inhibitor Compounds, Compositions and Methods for the Use Thereof in Anti-Viral Treatments

#22
20180258094
2018-09-13

Glucuronide prodrugs of tofacitinib

#23
20180235954
2018-08-23

LIPOSOMES USEFUL FOR DRUG DELIVERY

#24
20180186826
2018-07-05

Protected monomer and method of final deprotection for RNA synthesis

#25
20180169014
2018-06-21

Liposomes useful for drug delivery

#26
20180155761
2018-06-07

Cell-permeable probes for identification and imaging of sialidases

#27
20180133320
2018-05-17

5-ALA derivatives and use thereof

#28
20180118884
2018-05-03

Use of CO2 for the synthesis of cyclic glycocarbonates and linear polyglycocarbonates by polycondensation from glycans

#29
20180057474
2018-03-01

2,3-Fluorinated Glycosides as Neuraminidase Inhibitors and Their Use as Anti-Virals

#30
20170340624
2017-11-30

Liposomes useful for drug delivery

#31
20170079913
2017-03-23

Liposomes useful for drug delivery

#32
20170071858
2017-03-16

Liposomes useful for drug delivery

#33
20170022241
2017-01-26

Synthesis of amphiphilic calixarene glycoside detergents and use of same for extracting and stabilizing native functional membrane proteins

#34
20170022177
2017-01-26

Neuraminidase inhibitor compounds, compositions and methods for the use thereof in anti-viral treatments

#35
20170008858
2017-01-12

Process for the cycloaddition of a halogenated 1,3-dipole compound with a (hetero)cycloalkyne

#36
20160280732
2016-09-29

MOENOMYCIN ANALOGS, METHODS OF SYNTHESIS, AND USES THEREOF

#37
20160200755
2016-07-14

Glycoamino acid and use thereof

#38
20160145291
2016-05-26

Therapeutic monosaccharide-based inhibitors of hexokinase and glucokinase for parasitic diseases, along with methods of their formation and use

#39
20160095852
2016-04-07

Liposomes useful for drug delivery

#40
20160095817
2016-04-07

Liposomes useful for drug delivery

#41
20160068501
2016-03-10

2,3-Fluorinated glycosides as neuraminidase inhibitors and their use as anti-virals

#42
20160030341
2016-02-04

Liposomes useful for drug delivery

#43
20160009825
2016-01-14

Process for the functionalization of a surface

#44
20160002282
2016-01-07

Protected monomer and method of final deprotection for RNA synthesis

#45
20150337000
2015-11-26

Mannose-receptor selective lysinylated cationic amphiphiles and a process for preparation thereof

#46
20150225766
2015-08-13

Cell-permeable probes for identification and imaging of sialidases

#47
20150216838
2015-08-06

Neuraminidase inhibitor compounds, compositions and methods for the use thereof in anti-viral treatments

#48
20150182460
2015-07-02

Liposomes useful for drug delivery

#49
20150166593
2015-06-18

MODIFIED SACCHARIDES, CONJUGATES THEREOF, AND THEIR MANUFACTURE

#50
20150158899
2015-06-11

2,3-fluorinated glycosides as neuraminidase inhibitors and their use as anti-virals

#51
20150119354
2015-04-30

Moenomycin analogs, methods of synthesis, and uses thereof

#52
20150080326
2015-03-19

Pesticidal compositions

#53
20150079618
2015-03-19

Methods and compounds for identifying glycosyltransferase inhibitors

#54
20140378674
2014-12-25

Process for the preparation of certain triaryl rhamnose carbamates

#55
20140323422
2014-10-30

Anionic conjugates of glycosylated bacterial metabolite

#56
20140323412
2014-10-30

BILE ACID RECYCLING INHIBITORS FOR TREATMENT OF HYPERCHOLEMIA AND CHOLESTATIC LIVER DISEASE

#57
20140302554
2014-10-09

Non-ionic acid-labile surfactants and methods of use

#58
20140213584
2014-07-31

Selective glycosidase inhibitors and uses thereof

#59
20140155588
2014-06-05

Azacitidine process and polymorphs

#60
20140154298
2014-06-05

Liposomes useful for drug delivery

#61
20140135364
2014-05-15

Pesticidal compositions

#62
20140094429
2014-04-03

FGF RECEPTOR-ACTIVATING 3-O-ALKYL OLIGOSACCHARIDES, PREPARATION THEREOF AND THERAPEUTIC USE THEREOF

#63
20140088036
2014-03-27

POLYPHOSPHATE AND PYROPHOSPHATE DERIVATIVE OF SACCHARIDES

#64
20140088028
2014-03-27

Selective glycosidase inhibitors and uses thereof

#65
20140005191
2014-01-02

Selective glycosidase inhibitors and uses thereof

#66
20130122081
2013-05-16

Liposomes useful for drug delivery

#67
20120309954
2012-12-06

Non-ionic acid-labile surfactants and methods of use

#68
20120289691
2012-11-15

Protected monomer and method of final deprotection for RNA synthesis

#69
20120238737
2012-09-20

Thiocarbon-protecting groups for RNA synthesis

#70
20120190543
2012-07-26

Pesticidal compositions

#71
20120184606
2012-07-19

Neuraminidase inhibitor compounds, compositions and methods for the use thereof in anti-viral treatments

#72
20120178802
2012-07-12

2,3-fluorinated glycosides as neuraminidase inhibitors and their use as anti-virals

#73
20120172218
2012-07-05

Pesticidal compositions

#74
20120171283
2012-07-05

Liposomes useful for drug delivery

#75
20120148502
2012-06-14

Carbohydrate-mediated tumor targeting

#76
20120122805
2012-05-17

Pesticidal compositions

#77
20120046457
2012-02-23

PREPARATION OF DECITABINE

#78
20110245486
2011-10-06

Method for the production of 1,4-benzothiepin-1,1-dioxide derivatives

#79
20110224156
2011-09-15

Propionic acids, propionic acid esters, and related compounds

#80
20110201800
2011-08-18

Azacitidine process and polymorphs

#81
20110190233
2011-08-04

Anionic conjugates of glycosylated bacterial metabolite

#82
20110112044
2011-05-12

NOVEL USES OF D-MANNOPYRANOSE DERIVATIVES

#83
20110028738
2011-02-03

Photodissociable protective group

#84
20100292458
2010-11-18

Photolabile protective groups for improved processes to prepare oligonucleotide arrays

#85
20100292183
2010-11-18

TETRACYCLINE AND USES THEREOF

#86
20100076183
2010-03-25

PROTECTED MONOMER AND METHOD OF FINAL DEPROTECTION FOR RNA SYNTHESIS

#87
20100062991
2010-03-11

1,4-benzothiepin-1,1-dioxide derivatives which are substituted with fluorine, method for producing the same, drugs containing said compounds and use thereof

#88
20100056771
2010-03-04

Process of making 2-deoxy-2,2-difluoro-D-ribofuranosyl nucleosides and intermediates therefor

#89
20100035961
2010-02-11

1,4-benzothiepine 1,1-dioxide derivatives substituted by benzyl radicals, method for their preparation, pharmaceuticals comprising these compounds, and the use thereof

#90
20090209479
2009-08-20

Thiocarbon-protecting groups for RNA synthesis

#91
20090209476
2009-08-20

Pesticidal compositions

#92
20080207534
2008-08-28

1,4-benzothiazepine 1,1-dioxide derivative, process for its preparation, medicaments comprising this compound, and use thereof as a hypolipidaemic

#93
20080033172
2008-02-07

Mutagenic Heterocycles

#94
20080009496
2008-01-10

MUTAGENIC HETEROCYCLES

#95
20070298151
2007-12-27

Flavour modulating substances

#96
20070287673
2007-12-13

Monosaccharide derivatives

#97
20070196384
2007-08-23

Glycolipid adjuvant compositions

#98
20070116753
2007-05-24

Liposomes useful for drug delivery

#99
20070112184
2007-05-17

Production of carrageenan and carrageenan products

#100
20060263390
2006-11-23

Modified saccharides, conjugates thereof, and their manufacture

#101
20050096294
2005-05-05

Novel anti-coagulant

#102
16035625
2019-10-08

Alpha-selective sialyl donor and its uses for preparation of sialosides